VON HIPPEL-LINDAU SYNDROME: ASPECTS OF TREATMENT AND MANAGEMENT. CASE REPORT AND LITERATURE REVIEW

The steadily growing interest in studying of endocrine genetics is driven not only by the search for new pathologies but also by the most pressing need to develop methods for early diagnosis, treatment and management of patients. Though 20% of all the patients with von Hippel-Lindau syndrome do not have a family history of the disease; a genetic basis is a natural characteristic of the disease and determinates a phenotype. Despite the nonaggressive course, in general, a relative unpredictability of the syndrome signs onset and the lack of regular monitoring can increase the risk of surgery complications and cause a disability at a young age. The presented clinical case shows the need for a multidisciplinary approach to management of the patients with von Hippel-Lindau syndrome.

1. Wang Y., Liang G., Tian J., et al. Pedigree analysis, diagnosis and treatment in Von Hippel-Lindau syndrome: A report of three cases. Oncology Letters. 2018; 15(4): 4882-4890. doi:10.3892/ol.2018.7957.

2. Ershova E.V., Yukina M.Yu., Troshina E.A., et al. Von HippelLindau syndrome. Obesity and metabolism. 2011; 2(8): 65-68. doi:10.14341/2071-8713-4955. [In Russian].

3. Varshney N., Kebede A.A., Owusu-Dapaah H., et al. A Review of Von Hippel-Lindau Syndrome. J Kidney Cancer VHL. 2017; 4(3): 20–29. doi:10.15586/jkcvhl.2017.88.

4. Safronova Yu.V., Glukhov D.V., Strukova S.S., et al. Hippel-Lindau Disease. Oncology bulletin of the Volga Region. 2016; 4(26): 72-75 [In Russian].

5. Yukina M.Yu., Troshina E.A., Beltsevich. D.G., et al. Pheochromocytoma/paraganglioma: clinical and genetic aspects. Problems of endocrinology. 2013; 3(59): 19-26. doi:10.14341/probl201359319-26. [in Russian].

6. Chittiboina P., Lonser R.R. Von Hippel-Lindau disease. Handbook of clinical neurology. 2015; 132: 139-56. doi:10.1016/B978-0-44462702-5.00010-X.

7. Vortmeyer A.O., Alomari A.K. Pathology of the Nervous System in Von Hippel-Lindau Disease. Journal of kidney cancer and VHL. 2015; 2(3): 114-129. doi:10.15586/jkcvhl.2015.35.

8. Lonser R.R., Butman J.A., Huntoon K., et al. Prospective natural history study of central nervous system hemangioblastomas in von HippelLindau disease. Journal of neurosurgery. 2014; 5(120): 1055-62. doi:10.3171/2014.1.JNS131431.

9. Crespigio J., Berbel L.C. L., Dias M.A., et al. Von Hippel-Lindau disease: a single gene, several hereditary tumors. Journal of endocrinological investigation. 2018; 41(1): 21-31. doi: 10.1007/s40618-017-0683-1.

10. Girmens J.F., Erginay A., Massin P., et al. Treatment of von Hippel— Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas. American Journal of Ophthalmology. 2003; 136(1): 194—196. doi:10.1016/S00029394(03)00101-6

11. Chretien Y., Chauveau D., Richard S., et al. Treatment of von Hippel— Lindau disease with renal involvement. Progre s en urologie: journal de l’Association franc aise d’urologie et de la Socie te franc aise d’urologie. 1997; 7: 939—947. doi:10.1053/gast.2000.18143.

12. Maher E.R., Neumann H.P., Richard S. Von Hippel-Lindau disease: a clinical and scientific review. European Journal of Human Genetics. 2011; 19(6): 617-23. doi:10.1038/ejhg.2010.175.

13. Krauss T, Ferrara AM, Links TP et al. Preventive medicine for von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors. Endocr Relat Cancer. 25(9): ERC-18-0100 2018. doi:10.1530/ERC-18-0100.

14. Blansfield J.A., Choyke L., Morita S.Y., et al. Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs). Surgery. 2007; 142: 814–818. doi:10.1016/j.surg.2007.09.012.

15. Yaghobi J.A., Azadeh P. Von Hippel-Lindau Disease With MultiOrgan Involvement: A Case Report and 8-Year Clinical Course With Follow-Up. The American journal of case reports. 2017; 18: 1220-1224. doi:10.12659/AJCR.907356.

16. Ward TL, Zarrin-Khameh N. Papillary Cystadenoma: An Incidental Finding in Tubal Ligation. Case Rep Obstet Gynecol. 2018; 2018: 7964238. 2018 Apr 23. doi:10.1155/2018/7964238

17. Choyke P.L., Glenn G.M., Walther M.M., et al. von Hippel—Lindau disease: Genetic, clinical, and imaging features. Radiology 1995; 194: 629—642. doi:10.1148/radiology.194.3.7862955

18. Simpson J.L., Carson S.A., Cisneros P. Preimplantation genetic diagnosis (PGD) for heritable neoplasia. Journal of the National Cancer Institute. Monographs. 2005; 34: 87–90. doi:10.1093/jncimonographs/lgi027.

19. Grossman A., Johannsson G., Quinkler M., et al. Therapy of endocrine disease: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe. European journal of endocrinology. 2013;169(6): R165-75. doi:10.1530/EJE-13-0450